Indapamide/Delapril

吲达帕胺/地拉普利

Report date: 2023/04/21 17:46:58

Base Information

Drug NameIndapamide/Delapril
Drug Alias Name地拉普利和吲达帕胺Delapril/IndapamideIndapamide-Delapril mixt吲达帕胺+地拉普利Indapamide and Delapril +[11
ClassificationSmall molecules
Mechanisms of ActionSymporters inhibitorsAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzymeSymporters
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryItaly
Original Approved Date1997/12/01
Country/TerritoryItaly
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesChiesi Farmaceutici SPA
China Registration ClassN/A

Develop Information

Active CompaniesChiesi Farmaceutici SPA
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09BA12
Related LinksN/A